Profile

Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.